Introduction
============

Cardiovascular diseases comprise a complex pathological inflammatory process, including leukocyte migration and adhesion to vascular endothelial cells ([@b1-etm-0-0-3347],[@b2-etm-0-0-3347]). This process is mediated by adhesion molecules expressed on leukocytes and endothelial cells in response to inflammatory stimuli ([@b3-etm-0-0-3347]). Numerous soluble adhesion molecules are identified as plasma predictors for the risk of CVD, important among which are soluble intercellular adhesion molecule 1 (sICAM-1) and soluble P-selectin (sP-selectin)([@b1-etm-0-0-3347],[@b2-etm-0-0-3347],[@b4-etm-0-0-3347],[@b5-etm-0-0-3347]).

ICAM-1, also called CD54, is a member of the immunoglobulin supergene family ([@b6-etm-0-0-3347]). Being the ligand for the lymphocyte function associated antigen-1, ICAM-1 may facilitate leukocyte migration and adhesion ([@b7-etm-0-0-3347]). sICAM-1 may inhibit additional leukocyte adhesion, possibly resulting in inflammation inhibition ([@b8-etm-0-0-3347]). Thus, elevated expression levels of sICAM-1 may serve as a marker for atherosclerosis, the development of coronary heart disease and other CVD events ([@b9-etm-0-0-3347]--[@b12-etm-0-0-3347]).

P-selectin serves an important role in facilitating leukocyte and/or endothelial cell adhesion ([@b13-etm-0-0-3347]), platelet aggregation and stabilizing initial gpIIb/IIIa-fibrinogen interactions ([@b14-etm-0-0-3347]). The soluble form, sP-selectin, is proved to originate from the surface of the platelet membrane, particularly when thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome occur ([@b15-etm-0-0-3347]--[@b17-etm-0-0-3347]). Raised sP-seletin expression levels are observed in stable peripheral artery disease and stable coronary artery disease ([@b18-etm-0-0-3347]). In addition, higher expression levels of sP-selectin are associated with patients with CVD ([@b19-etm-0-0-3347]).

A meta-analysis reported that the ABO blood group, blood group A in particular, is associated with a higher risk of myocardial infarction, peripheral vascular disease, strokes and venous thromboembolism ([@b20-etm-0-0-3347]), suggesting that it may have a role in inflammatory adhesion. Notably, the circulating expression levels of sICAM-1 and sP-selectin are reported to be significantly associated with ABO blood group antigens in Caucasian populations ([@b21-etm-0-0-3347]--[@b23-etm-0-0-3347]).

The distribution and variations of ABO blood group antigens differ considerably among races; however, it is uncertain whether the observed association in Caucasians is due to race specificity ([@b21-etm-0-0-3347],[@b22-etm-0-0-3347]). Until now no reports are available in other populations. In addition, in previous studies of patients with inflammatory diseases, the data collected may be influenced by the inflammatory response itself, as both sICAM-1 and sP-selectin participate in the inflammatory process ([@b7-etm-0-0-3347],[@b13-etm-0-0-3347]). Whether the association observed in patients is the same as in healthy individuals was not clarified ([@b21-etm-0-0-3347],[@b22-etm-0-0-3347]). In order to address these issues, the association of ABO with sICAM-1 and sP-selectin in a healthy Chinese population was investigated in the present study.

Materials and methods
=====================

### Specimen collection and serological testing of blood types

ABO blood groups are not evenly distributed in China ([@b24-etm-0-0-3347]). In particular, the AB blood group accounts for \~10% among the four major groups, not to mention the rare subtypes ([@b24-etm-0-0-3347]). As specimens were collected for the current study by the Blood Collection Department of the Blood Center (Blood Center of Shandong, Jinan, China) during the period between April 2013 and March 2014, the aim of the study was described to the blood donors for informed consent and their physical data, including age, gender, smoking status, height and weight were recorded. In order to avoid the distribution imbalance of the four blood groups, the plasma specimens were collected from EDTA blood specimens previously tested in the Clinical Laboratory of the Blood Center (Blood Center of Shandong, Jinan, China), a department responsible for the primary testing of the blood samples from the donors. In this department, each blood sample could be matched with the donor information through their serial number, and the qualified blood samples (for which the potential viruses such as syphilis, hepatitis B, hepatitis C and AIDS are examined, and the unqualified blood samples can be excluded) were grouped into four blood types (A, B, O and AB). A total of 200 samples were randomly collected from each blood group stored within 24 h in this department, ensuring that the donors were healthy. All the speciments were kept at −30°C until further use.

The participants were characterized by age, gender (according to the Blood Donation Law, the donor ages should range between 18 and 55 years old), smoking status and mean body mass index (BMI). All participants had normal blood pressure levels (90 mmHg-140 mmHg/60 mmHg-90 mmHg) and normal metabolic conditions (namely, normal values of hemoglobin and transaminase, heavy enough, good nutrition, without alcohol or any other illnesses for which blood donation is not permitted). Samples were from patients with no prior histories of CVD, diabetes or other chronic illness. Those with high blood lipid and cholesterol levels, and abnormal transaminase levels, were excluded; only eligible and clear plasma was included in the study. All blood donors provided written informed consent for this research. This study was approved by the Ethics Committee of the Blood Center of Shandong Province (Jinan, China). The blood groups were carefully detected using forward and reverse typing (Sanquin Reagents, Amsterdam, The Netherlands).

### Determination of sICAM-1 and sP-selectin expression levels

The circulating sICAM-1 expression level was determined by a quantitative ELISA kit (cat no. CHE0052; 4A Biotech Co., Ltd., Beijing, China) according to the manufacturer\'s instructions. EDTA-anti-coagulated plasma from each sample was run in duplicate wells and the intra- and inter-assay coefficients of variation were both \<10%. The minimum detectable dose was 60 pg/ml, with a standard curve ranging 0--5,000 pg/ml.

The sP-selectin expression level was examined from plasma with a quantitative ELISA kit (BMS219/4; eBioscience, Inc., Vienna, Austria) with a minimum detectable dose of 0.2 ng/ml. EDTA-anti-coagulated plasma from each sample was run in duplicate wells and the intra- and inter-assay coefficients of variation were 7.8 and 5.4%, respectively.

### Standard genotyping of ABO blood groups

Genomic DNA was extracted from blood samples using a QIAamp DNA Blood Mini kit (51104; Qiagen, Inc., Valencia, CA, USA) according to the manufacturer\'s instructions. *ABO* allele genotyping was performed with a commercially available kit (B9801B; G&T SSPTyper; G&T Biotech, Inc., Rockville, MD, USA). The DNA polymerase was commercially available (M1665S; Promega Corp., Madison, WI, USA). Polymerase chain reaction (PCR) analysis was performed in a 10 µl reaction volume, containing 1 µl template DNA (0.04--0.07 µg DNA), 1 µl Taq polymerase (0.33--0.5 µg), 0.2 mmol/l dNTPs, and the primers were previously coated inside the tube provided by the G&T kit. Next, the PCT analysis was performed in a 9600 DNA Thermal Cycler (PE Biosystems, Foster City, CA, USA) under the following thermal cycling conditions: 95°C for 5 min, followed by 30 cycles, including 95°C denaturation for 30 sec, specific annealing at 60°C for 30 sec and extending at 72°C for 90 sec. The system was then extended at 72°C for 5 min. Finally, 3% agarose gel electrophoresis was conducted to analyze the PCR results (Electrophoresis apparatus: DYY-6D type, Liuyi Instrument Factory, Beijing, China; Electrophoresis tank: ABgene, ThermoFisher Scientific Inc., Waltham, MA, USA). The results were investigated under a UV transilluminator (GeneGenius, Syngene, Frederick, MD, USA). The image was analyzed using the GeneSnap software (Product version 7.01, SynGene, Cambridge, England).

### Statistical analysis

One-way analysis of variance was performed to analyze the association of ABO blood group antigens and the *A1* gene with circulating expression levels of sICAM-1 and sP-selectin. The Student\'s t-test was used for comparison between the two groups where appropriate. P\<0.05 was considered to indicate a statistically significant difference. All statistical analyses were performed SPSS version 16.0 (SPSS, Inc., Chicago, IL, USA).

Results
=======

### Patient characteristics

As blood donors, the physical conditions of the study participants did not vary greatly ([Table I](#tI-etm-0-0-3347){ref-type="table"}). The influence of characteristics, such as age, gender, smoking status and BMI, on the expression levels of sICAM-1 and sP-selectin were analyzed in each blood group using a Student\'s t-test. However, no statistically significant differences were observed among the characteristics (data not shown).

### Blood group antigen A is associated with the lowest expression levels of sICAM-1 and sP-selectin

In previous studies, antigen A has been suggested to be associated with abnormal expression levels of sICAM-1 and sP-selectin in Caucasians ([@b21-etm-0-0-3347],[@b22-etm-0-0-3347]). These contradictory results may have been partially affected by the method by which participants were collected, as the distribution imbalance of blood groups and the disease status of the participants may have been the influencing factors. Thus, the association of blood groups with the expression levels of sICAM-1 and sP-selectin were detected in a healthy population in the present study. Blood group A individuals were found to have significantly lower sICAM-1 expression levels (252.2 ng/ml), compared with those in group O (304.4 ng/ml; P=0.002). In addition, blood group A individuals were associated with the lowest concentration of sP-selectin (49.2 ng/ml), followed by group AB (52.9 ng/ml), both of which were significantly lower compared with group O (P\<0.000 and P=0.007, respectively; [Table II](#tII-etm-0-0-3347){ref-type="table"}). These results indicate that in a Chinese healthy population, blood group antigen A is associated with the lowest expression levels of sICAM-1 and sP-selectin.

### A1 gene is associated with the lowest expression levels of sICAM-1 and sP-selectin

Each blood group comprises several subgroups, depending on the blood group gene it contains ([@b25-etm-0-0-3347]). For example, blood group A consists of subgroups including group A2, A3 and Ax and the A1 antigen is the most commonly expressed in Asians ([@b26-etm-0-0-3347]). It is therefore important to determine the association between specific blood group genes and the expression levels of sICAM-1 and sP-selectin. As antigen A was demonstrated to be associated with the lowest sICAM-1 and sP-selectin expression levels in the present study, a standard genotyping assay in groups A and AB was performed to further characterize the differences between subgroups ([Table III](#tIII-etm-0-0-3347){ref-type="table"}). Among group A participants, individuals with genotypes *A1*/*O* and *A1*/*A1* numbered 176 and 22, respectively. As there were only two *A2*/*O* individuals, they were not included in this analysis. The sICAM-1 expression levels in the genotype *O*/*O* were compared to the expression levels in genotypes the *A1*/*O* and *A1*/*A1*, and the *A1*/*A1* subgroup was found to have a lower circulating expression level (P\<0.001) than the *A1*/*O* genotype (P=0.002). In the AB group, there were 182 *A1*/*B* and 18 *A2*/*B* individuals. sP-selectin expression levels in the *O*/*O* genotype were compared with the *A1*/*B* and the *A2*/*B* genotypes, and the *A1*/*B* genotype was found to have a significantly expression lower level (P\<0.001) than the *A2*/*B* genotype (P=0.01) ([Fig. 1](#f1-etm-0-0-3347){ref-type="fig"}). These results indicate that the *A1* gene is associated with the lowest expression levels of sICAM-1 and sP-selectin.

Discussion
==========

Instead of encoding ABO blood group antigens directly, the *ABO* gene encodes glycosyltransferases that transfer distinct monosaccharides to the precursor H antigen to form ABO blood group antigens ([@b27-etm-0-0-3347],[@b28-etm-0-0-3347]). The gene *A* encodes stronger transferase activity compared with the other alleles, and the *A1* allele encodes the strongest ([@b29-etm-0-0-3347]). In the present study, the lower expression levels of sICAM-1 and sP-selectin found in donors with the *A1* allele compared with the *A2* allele reflects the *A1* allele having 30--50 fold more A transferase activity than the *A2* allele ([@b18-etm-0-0-3347]). The frequency distributions of the ABO blood group antigens vary considerably among races. In the European population, the frequency of the A antigen (25--55%) is much higher than in other parts of the world, while in aboriginal Americans and the majority of native Australians, the B antigen has a very low frequency ([@b30-etm-0-0-3347]). Conversely, the B antigen is very common in Asians (20--30%). There are also variations between the *ABO* alleles within races ([@b31-etm-0-0-3347]).

Previous studies have shown the association of ABO blood groups with sICAM-1 and sP-selectin expression levels ([@b21-etm-0-0-3347],[@b22-etm-0-0-3347] and [@b32-etm-0-0-3347]). In a European ancestry population, it was observed that the *A1* blood group allele was associated with the lowest expression levels of these proteins ([@b32-etm-0-0-3347]). In a study of a group of Caucasian women without chronic disease history, the *A1* allele was associated with the lowest sICAM-1 expression level, while the *A2* allele was associated with a slightly higher expression level, intermediate between the *A1* and *O* alleles ([@b21-etm-0-0-3347]). The data in the current study were compatible with the above two studies. However, in a case-control study within a Caucasian population, contradictory results were found, associating blood group A with the highest sICAM-1 expression level ([@b22-etm-0-0-3347]). This discordant result may be due to the specific selection of participants, namely whether the individuals were healthy or had a history of CVD, or how they were grouped when the data were collected. There may also be an inflammatory response of adhesion molecules in patients, and genetic variations in patients with a history of chronic illness may affect the inflammatory adhesion process. The observation of significantly increased expression levels of sICAM-1 in completely healthy individuals compared with patients with CVD remained unexplained. Furthermore, variations in population and subpopulation, and the varied distribution of ABO blood groups within races, may also contribute towards the difference. In the present study, the significantly reduced expression levels of sICAM-1 and sP-selectin were observed in completely healthy participants. Furthermore, the possible distribution imbalance of blood groups was also excluded. In addition to previous studies ([@b9-etm-0-0-3347]--[@b12-etm-0-0-3347],[@b19-etm-0-0-3347],[@b20-etm-0-0-3347]), the authors of the current study speculate that the risk of suffering from CVD may be higher if sICAM-1 or sP-selectin expression levels are elevated in group A individuals. However, this hypothesis requires further investigation.

It is important to note the role of ABO blood group antigens in the inflammatory adhesion process. Aside from its association with CVD ([@b20-etm-0-0-3347]), the presence of the A antigen is understood to be closely associated with severe malaria infection ([@b33-etm-0-0-3347]). In China, pancreatic cancer was detected more frequently in group A patients compared with group O patients, and the Tumor Node Metastasis staging was significantly increased in the non-O group ([@b34-etm-0-0-3347]). In Japanese and Taiwanese populations, individuals with blood group A were detected to have a higher susceptibility to inflammation and cancer ([@b35-etm-0-0-3347],[@b36-etm-0-0-3347]). This may be due to the low level of soluble forms of adhesion molecules in group A individuals, with a conversely high concentration of membrane forms, which could mediate leukocyte migration and adhesion in response to inflammatory stimuli ([@b7-etm-0-0-3347],[@b13-etm-0-0-3347]).

The detailed mechanism underlying the observed association of sICAM-1 and sP-selectin with the ABO blood group remains elusive. The glycosylation process of ABO antigens may affect the shedding or clearance of soluble adhesion molecules, as soluble and cellular forms of ICAM-1 are known to be glycosylated ([@b37-etm-0-0-3347]). Additionally, glycosylation is crucial to the binding activity of the P-selectin receptor, P-selectin glycoprotein ligand-1 ([@b38-etm-0-0-3347]). In the present study, the lower expression levels of sICAM-1 and sP-selectin found in donors with the *A1* allele compared with the *A2* allele may reflect the stronger shedding or clearance ability of the *A1* allele, as the *A1* allele has 30--50 fold more A transferase activity than the *A2* allele ([@b23-etm-0-0-3347]). The pursuit of further investigation into this topic is encouraged.

In conclusion, by using phenotype and genotype assay methods, it is confirmed that the ABO blood group and the *A* allele are significantly associated with the lowest circulating sICAM-1 and sP-selectin expression levels in a healthy Chinese population, independent of variations and distributions of ABO blood groups among races. As blood group A is detected to be associated with the lowest sICAM-1 and sP-selectin expression levels in healthy Asian individuals, it is suggested that ABO blood groups be considered when abnormal elevated sICAM-1 and sP-selectin expression levels are perceived as predictors for risk the of CVD. In addition, the present data provide evidence for the previously unknown role of ABO blood group antigens in the inflammatory adhesion process, and contribute towards the understanding of the underlying mechanism of the pathological inflammatory adhesion process.
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###### 

Characteristics of participants in the various blood groups.

                                       Blood groups                             
  ------------------------------------ -------------- ------------ ------------ ------------
  Individuals, n                       200            200          200          200
  Median age, years                    33.5           38.2         35.7         40.3
  Age range, years                     22--50         24--53       21--51       23--52
  Gender                                                                        
    Male                               130            128          129          132
    Female                             70             72           71           68
  Currently smoking, %                 25.7           27.3         28           26.8
  Mean body mass index, kg/m^2^ (SD)   23.1 (4.7)     22.8 (3.6)   22.7 (3.2)   23.2 (2.8)

SD, standard deviation. Student\'s t-test was used to analyze the influence of gender and smoking status on the expression levels of sICAM-1 and sP-selectin inside each blood group. One-way analysis of variance was used to analyze the differences of age, gender, smoking status, and body mass index among the four blood groups. sICAM1, soluble intercellular adhesion molecule 1; sP-selectin, soluble P-selectin.

###### 

Association of ABO blood group antigens with expression levels of sICAM1 and sP-selectin.

  Protein       Blood group                                       Expression (ng/ml)   P-value
  ------------- ------------------------------------------------- -------------------- ---------
  sICAM1        O^[a](#tfn3-etm-0-0-3347){ref-type="table-fn"}^   304.4 (7.3)          --
                A                                                 252.2 (6.7)            0.002
                B                                                 272.9 (9.6)          0.08
                AB                                                295.8 (8.1)            0.682
  sP-selectin   O^[a](#tfn3-etm-0-0-3347){ref-type="table-fn"}^     64.5 (3.1)         --
                A                                                   49.2 (3.9)         \<0.001
                B                                                   59.3 (4.4)           0.188
                AB                                                  52.9 (4.6)           0.007

One-way analysis of variance was used to analyze the expression levels of sICAM1 and sP-selectin among the four blood groups

Levels of sICAM-1 and sP-selectin in A, B and AB blood groups were compared with those in blood group O. sICAM1, soluble intercellular adhesion molecule 1; sP-selectin, soluble P-selectin.

###### 

Association between ABO genotypes, and sICAM1 and sP-selectin expression levels.

  Genotype    Subjects (n)   sICAM-1 (ng/ml)                                             P-value   sP-selectin (ng/ml)                                        P-value
  ----------- -------------- ----------------------------------------------------------- --------- ---------------------------------------------------------- ---------
  *A1*/*O*    176            253.2 (6.2)                                                 0.002     49.5 (3.8)                                                 0.001
  *A1*/*A1*   22             244.6 (3.7)                                                 \<0.001   46.8 (4.1)                                                 \<0.001
  *A1*/*B*    182            295.3 (8.5)                                                 0.679     52.5 (4.7)                                                 \<0.001
  *A2*/*B*    18             300.9 (7.6)                                                 0.735     57.5 (3.2)                                                 0.01
  *O*/*O*     200            304.4 (7.3)^[a](#tfn5-etm-0-0-3347){ref-type="table-fn"}^   --        64.5 (3.1)^[b](#tfn6-etm-0-0-3347){ref-type="table-fn"}^   --

One-way analysis of variance was used to analyze the results.

sICAM-1 expression levels in *A1*/*O* and *A1*/*A1* groups were compared with that in the *O*/*O* group.

sP-selectin expression levels in *A1*/*B* and *A2*/*B* groups were compared with that in the *O*/*O* group. sICAM1, soluble intercellular adhesion molecule 1; sP-selectin, soluble P-selectin.
